4.7 • 1.6K Ratings
🗓️ 26 August 2015
⏱️ 48 minutes
🧾️ Download transcript
Just 24 hours after the surprise FDA approval of the Dexcom G5 continuous glucose monitoring system, I spoke with Dexcom EVP Steven Pacelli and asked him all of the questions that were submitted to me by my blog readers and podcast listeners - I even threw in a few of my own.
If you're wondering about Dexcom G5 upgrading, cost, out of pocket, battery life and more? This is the podcast for you!
Steven was named Executive Vice President of Strategy and Corporate development in 2012. Mr. Pacelli has served in roles of increasing responsibility with Dexcom since 2006, including its Chief Operating Officer from 2010 to 2012, its Chief Administrative Officer from 2008 to 2010, its Senior Vice President of Corporate Affairs from 2007 to 2008, and its Vice President of Legal Affairs from 2006 to 2007.
Show Notes
Subscribe to the podcast on iTunes today!
Find out more about Dexcom
Read the G5 Press release, see images of the device and more.
Check out my type 1 diabetes parenting blog Arden's Day
Listen to the Juicebox Podcast online
Read my award winning memoir: Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad
Follow Scott on Social Media
On Twitter @ArdensDay @JuiceboxPodcast
On Facebook Arden's Day - Juicebox Podcast
On Instagram @ArdensDay @JuiceboxPodcast
Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.
Click on a timestamp to play from that location
0:00.0 | Hey, welcome to the Juice Box Podcast episode 28. This episode is going to be a conversation with Steve |
0:07.9 | Passelli. Steve is the Executive Vice President Strategy and Corporate Development for Dexcom and |
0:16.7 | Basil's pretty loud in the background today. But anyway so listen so you know about 10 days ago Google and DexCom make this announcement that they've kind of formed a partnership. |
0:26.8 | I saw a lot of excitement online about it. |
0:28.4 | I reached out and was able to talk to the CEO of Dexcom, Kevin Sayer, about the announcement. |
0:34.0 | We chatted about Dexcom in general in episode 27. |
0:38.7 | And then a week and a half later, very unexpected for everybody. |
0:43.2 | DexCom received FDA approval for their DexCom |
0:45.8 | Generation 5, their G5 product, months ahead |
0:49.2 | of when they expected. |
0:50.7 | It made another big splash online, and I thought, well, you know, Kevin got such a great response |
0:57.4 | on the podcast and was so open and conversational. |
1:00.4 | Let me see who else is over there at Dexcom that might want to talk on the |
1:04.0 | podcast. And we found Steve. So did the same thing, you can hear Dexcom's beeping in the background |
1:09.7 | at my house. Did the same thing, I reached out on Facebook and on my blog at |
1:13.4 | Arden's Day.com I asked for people's initial questions about the G5 |
1:17.8 | lunch and put them in some sort of order that made sense to me and I had a |
1:20.7 | conversation with Steve just now just now about the questions and he did |
1:26.2 | his best to answer all of them. I think he got through everyone I asked him and I found |
1:31.1 | that there were satisfactory answers to everything he said and so we really appreciate Steve coming on thank you Steve and I appreciate everybody out in the community who offered up questions. I know I didn't get to everyone, but there are in specific but great answers for Canadian and European listeners, so hold on for that. |
1:48.0 | And just a lot of stuff about little worries when something's, you know, first announced that you start, you have concerns about, |
1:55.2 | but then somebody kind of belays them for you. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Scott Benner, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Scott Benner and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.